A Phase-I Clinical Trial of Donor-Derived MIC Cell Infusion for the Induction of Donor-Specific Hyporesponsiveness after Living Donor Kidney Transplantation (TOL-1 study)
2018 ◽
Vol 33
(suppl_1)
◽
pp. i320-i320
2020 ◽
Vol 76
(5)
◽
pp. 616-623
◽
2018 ◽
Vol 13
(4)
◽
pp. 312-318
◽
2012 ◽
Vol 44
(1)
◽
pp. 270-272
◽
2012 ◽
Vol 59
(6)
◽
pp. 849-857
◽
2005 ◽
Vol 130
(36)
◽
pp. 2039-2042
◽
2006 ◽
Vol 6
(8)
◽
pp. 1841-1847
◽